FDA Investigator Ivis L Negron

Ivis L Negron has inspections in 7 countries as of 30 Oct 2023. Ivis L Negron has collaborated with a combinined 1987 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
13
Last Inspection Date:
30 Oct 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
100002430
Country:
China, Puerto Rico, United Kingdom of Great Britain and Northern Ireland, United States of America, Taiwan, Japan, France
Co-Investigator(s):
Adalberto Cajigas, Adaliz Santaliz Cruz, Agnes M Santori, Angelica M Hernandez, Anita R Michael, Ann L Demarco, Annette Melendez, Ariel Cruz Figueroa, Arlene M Badillo, Arsen Karapetyan, Arwa S El Hagrasy, Binh T Nguyen, Bo Chi, PhD, Brenda Rivera, Brenda S Zimmer, PhD, Carlos A Medina, CDR Ileana Barreto Pettit, Chelsea N Sealey, Christina Capacci Daniel, PhD, Colleen Thomas, PhD, Constance Y Fears, Dayna I Martinez, Dennis Cantellops Paite, Donna Christner, Douglas C Kovacs, Dr. Carmelo Rosa, Dr. Sriram Subramaniam, PhD, Edwin Martinez, Erika E Englund, PhD, Fredrick L Fricke, German Rivera, Hector J Colon Torres, Iraida Ortiz, Ivis Lnegron Torres, Javier O Vega, Jorge L Gonzalez, Jorge L Guadalupe, Jose A Cruz, Jose A Moreno, Jose Acruz Gonzalez, Jose Alopez Rubet, José E Meléndez, Jose E Melendez, DDC, Jose F Pedro, Jose Fpedrode Jesus, Jose Melendez, Jose R Lopez, Jose Velez, Karen A Wolnik, Karl D Hezel, Kevin A Gonzalez, Laiza V Garcia, Laurimer Kuilan Torres, Lequita M Mayhew, Libia M Lugo, Lisa M Lopez, Lourdes Andujar, Lucas B Leake, M Patriciaurphy Murphy, Margarita Santiago, Marianela Aponte, Marianela Aponte Cruz, Mark C Saale, Megan A Haggerty, Michael A Charles, Michael J Kuchta, Michelle Y Clark Stuart, Miguel A Martinez, Miguel Hernandez Sanchez, Milva E Melendez, Min Tang, Monica E Caphart, Muralidhara B Gavini, PhD, Myriam M Sosa, Noreen Muniz, Noreen Muñiz, Patrick C Klotzbuecher, Paul L Bellamy, Paula J Bretz, Rafael Nevarez Nieves, Rakhi B Shah, Ralph H Vocque, Ramesh Potla, PhD, Ramon A Hernandez, Raquel Gonzalez Rivera, Rebeca M Melendez, Rebecca Parrilla, Rebecca Rodriguez, Regina T Brown, Robert M Barbosa, Robert Sharpnack, Sangeeta M Khurana, PhD, Santos E Camara, Sharmista Chatterjee, Sharon K Thoma, PharmD, Shelby N Marler, Sonia M Monges, Steven B Barber, Steven E Bowen, PhD, Thomas J Arista, Thuy T Nguyen, LCDR, Timothy T Kapsala, Uttaniti Limchumroon (Tom), Vilmary Negron Rodriguez, Wanda J Torres, Yeissa Chabrier Rosello

Ivis L Negron's Documents

Publish Date Document Type Title
April, 2001 FDA 483 Charles River Laboratories Edinburgh Ltd. - Form 483, 2001-04-05
July, 2010 FDA 483 Yuki Gosei Kogyo Co., Ltd. - Form 483, 2010-07-21
October, 2001 FDA 483 Kongo Chemical Co. LTD - Form 483, 2001-10-17
September, 2007 FDA 483 Syn-Tech Chem. & Pharm. Co., Ltd. - Form 483, 2007-09-20
September, 2017 FDA 483 Bristol-Myers Squibb Holdings Pharma, Ltd. Liability Company - Form 483, 2017-09-11
February, 2000 FDA 483 Janssen Ortho LLC - Form 483, 2000-02-18
May, 2011 FDA 483 Asymchem Life Science (Tianjin) Co., Ltd. - Form 483, 2011-05-18
May, 2009 FDA 483 Baxter Healthcare Corporation - Form 483, 2009-05-14
March, 2016 FDA 483 AbbVie Biotechnology LTD - Form 483, 2016-03-24
April, 2001 FDA 483 Response Charles River Laboratories Edinburgh Ltd. - Form 483R, 2001-05-23
February, 2000 EIR Janssen Ortho LLC - EIR, 2000-02-18
October, 2001 FDA 483 Yuki Gosei Kogyo Co. LTD - Form 483, 2001-10-12
June, 2001 FDA 483 Schering-Plough Products LLC - Form 483, 2001-06-13
February, 2002 EIR Bristol-Myers Squibb Manufacturing Company Unlimited Company - EIR, 2002-02-28
September, 2013 FDA 483 Minakem Beuvry Production - Form 483, 2013-09-13
April, 2001 EIR Charles River Laboratories Edinburgh Ltd. - EIR, 2001-04-05

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more